Physician profile
Charles W Bower
NPI 1245289446
$10,990.65
in general payments reported to CMS, 2019-2025
34 companies · $1,433 in 2025
The $1,433 reported for 2025 was more than what 88% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $546 · 2020: $120 · 2021: $78.86 · 2022: $376 · 2023: $4,727 · 2024: $3,710 · 2025: $1,433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,587 · Travel and Lodging: $4,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,587.38 |
| Travel and Lodging | $4,282.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,481.58 | 2019-2025 | Obsidio, Embold Fibered, Axios |
| Abbott Laboratories | $2,410.94 | 2023-2025 | Supera, Perclose Prostyle, Esprit |
| Medtronic, INC. | $2,031.09 | 2022-2025 | Turbohawk, Symplicity G3, Hawkone |
| Penumbra, INC. | $1,837.12 | 2019-2025 | Indigo System, Penumbra System |
| Endologix LLC | $491.05 | 2019-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Angiodynamics, INC. | $264.81 | 2023-2025 | Auryon Laser System 100-120 Vac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $171.49 | 2022-2025 | Lifevest |
| Stryker Corporation | $123.37 | 2023 | Spinejack |
| Terumo Medical Corporation | $119.54 | 2023 | Azur Cx Detachable |
| Novartis Pharmaceuticals Corporation | $97.86 | 2022-2024 | |
| Philips North America LLC | $96.66 | 2019 | |
| Janssen Pharmaceuticals, INC | $86.08 | 2022 | |
| Bard Peripheral Vascular, INC. | $81.67 | 2021-2025 | Trek |
| Edwards Lifesciences Corporation | $70.95 | 2020 | |
| W. L. Gore & Associates, INC. | $59.96 | 2024-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $53.67 | 2023-2025 | Resonance, Lunderquist |
| Teleflex LLC | $49.61 | 2025 | Orsiro Mission, Vascband |
| Cardiovascular Systems INC. | $48.16 | 2019-2022 | |
| Imperative Care, INC | $45.77 | 2025 | Prodigy Catheter, Symphony Catheter |
| Surmodics, INC. | $45.15 | 2025 | Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy System |
| Pharmacyclics LLC, An Abbvie Company | $43.16 | 2021 | |
| Shockwave Medical, INC | $39.20 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Histosonics, INC. | $36.35 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $33.18 | 2024 | Arcalyst |
| Abiomed | $27.79 | 2024 | Impella |
| Sirtex Medical INC | $23.12 | 2024 | Lava Les (Liquid Embolic System) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.04 | 2023 | Jardiance |
| Amgen INC. | $16.52 | 2024 | Repatha |
| Veryan Medical Incorporated | $15.71 | 2025 | Biomimics 3d Vascular Stent System |
| Merck Sharp & Dohme LLC | $15.10 | 2023 | Verquvo |
| Pfizer INC. | $14.62 | 2023 | |
| 3m Company | $14.46 | 2019 | |
| Cordis US Corp. | $13.86 | 2025 | Mynxgrip |
| Lexicon Pharmaceuticals, INC. | $13.01 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Bower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.